Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 259-910-3 | CAS number: 55934-93-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
GLP-studies according to OECD guidelines 401 and 402 are available for tripropylene glycol butyl ether. This data is supported by non-GLP studies equivalent to OECD guidelines 401 and 402 .
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1988
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was carried out under GLP and in conformity with the OECD guideline for Testing of Chemicals No.401: "Acute oral toxicity".
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Wiga GmbH, SPF- quality, randomly bred
- Age at study initiation: 11 weeks old
- Fasting period before study: 3-4 hours
- Housing:Polycarbonate cages containing purified sawdust as bedding material.
- Diet (e.g. ad libitum): Ad libitum
- Water (e.g. ad libitum):Ad libitum
- Acclimation period:5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-23°C
- Humidity (%): 65-85°C
- Photoperiod (hrs dark / hrs light): 12 hrs dark/12 hrs/light
Pilot study
IN-LIFE DATES: From: 18-08-1987 To:25-08-1987
Main study
IN-LIFE DATES: From: 02-09-1987 To:16-09-1987 - Route of administration:
- oral: gavage
- Vehicle:
- not specified
- Details on oral exposure:
- VEHICLE
MAXIMUM DOSE VOLUME APPLIED:
Dose range finding: 5000mg/kg
Main study: 4200 mg/kg
DOSAGE PREPARATION (if unusual): The dose volume (ml/kg body weight) was calculated as follows;
Dosis: g/kg body weight/specific gravity in (g/ml). The specific gravity used was 0.09284 g/ml.
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: Based on the toxicity observed in the dose range finding investigation three groups of animals, each comprising 5 males and 5 females, were dosed with a single oral dose of the test substance at 2400, 3200 and 4200 mg/kg body weight, respectively. - Doses:
- single dose of 2400, 3200, and 4200 mg/kg bw
- No. of animals per sex per dose:
- 30
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Daily
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight,organ weights, histopathology. - Statistics:
- Established statistical procedure (e.g. Finney,1971)
- Preliminary study:
- Three groups of animals, each comprising 1 male and 1 female, were dosed with a single oral dose of the test substance at 2500, 4000 and 5000 mg/kg body weight, respectively. Both animals of the 4000 mg/kg and 5000 mg/kg dose groups died with in 24 hours of dosing. Symptoms of toxicity were ataxia, lethargy, tremors, convulsions, unreactive, piloerection and abnormal respiration (i.e., dyspnoea, bradypnoea, rattled respiration). Animals of the low dose group showed as of day 3 no more signs of toxicity. The observation period was 7 days.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- ca. 2 800 mg/kg bw
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 3 100 mg/kg bw
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 2 600 mg/kg bw
- Mortality:
- The incidence of mortalities for the sexes combined from low to high dose group was 3, 6 and 10. All deaths occured within 24 hours of dosing.
- Clinical signs:
- other: Major signs of toxicity were lethargy, ataxia, convulsions, tremors and unreactiveness. For surviving animals these signs were reversible since as of day 2 no more significant abnormalities were observed during the 14-day observation period.
- Gross pathology:
- Macroscopic examination of animals at necropsy revealed bloody nose, bloody eye encrustation, moist eyes, red patches in the glandular part of the stomach and in the pancreas, petechiae of the stomach and the thymus, bloody contents or haemorrhage of the small intestine, haemothorax and dark red lungs.
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The LD50 value for the sexes combined amounted to 2.8 g/kg body weight, whereas the LD50 values for the sexes separately were 3.1 and 2.6 g/kg for males and females, respectively.
- Executive summary:
The purpose of the study was to obtain information on the toxicity of the test substance when administered to rats in a single oral dose. Furthermore, the study was intended to derive the LD50. The study was conducted according to OECD guideline 401.
Three groups of 5 male and 5 female, young adult rats of wistar strain were used to access the acute toxicity study of Tripropylene glycol n-butyl ether. Animals were fasted overnight prior to dosing until 3 -4 hours after administration of the test substance.The undiluted test substance was administered once only by gavage at a dose level of 2400, 3200 and 4200 mg/kg body weight respectively.
The incidence of mortalities for the sexes combined from low to high dose group was 3, 6 and 10. All deaths occurred within 24 hours of dosing. Major signs of toxicity were lethargy, ataxia, convulsions, tremors and unreactiveness. For surviving animals these signs were reversible since as of day 2. No more significant abnormalities were observed during the 14 day observation period. All surviving animals showed body weight gain during the study period.
Macroscopic examination of animals at necropsy revealed bloody nose, bloody eye encrustation, moist eyes, red patches in the glandular part of the stomach and in the pancreas, petechiae of the stomach and the thymus, bloody contents or haemorrhage of the small intestine, haemothorax and dark red lungs.
The LD50 value for the sexes combined was calculated to be approximately 2800 mg/kg body weight. The LD50 values for the sexes separately were 3100 and 2600 mg/kg for males and females, respectively.
Reference
The incidence of mortalities for the sexes combined from low to high dose group was 3, 6, and 10. All deaths occurred within 24 hours of dosing. Major signs of toxicity were lethargy, ataxia, convulsions, tremors and
unreactiveness. For surviving animals these signs were reversible since as of day 2 no more abnormalities were
observed during the 14-day observation period. Major macroscopic abnormalities of animals at necropsy were bloody nose, bloody eye encrustation, red patches in the glandular part of the stomach and in the
pancreas, petechiae of the stomach and
the thymus, bloody contents or haemorrhage of the small
intestine, haemothorax and dark red lungs.
The LD50-value of DOWANOL TPnB for the sexes combined
amounted to 2.8 g/kg body weight, whereas the LD50-values
for the sexes separately were 3.1 and 2.6 g/kg for males and
females, respectively.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 600 mg/kg bw
- Quality of whole database:
- Good (Klimisch 1)
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1988
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: This study was conducted under GLP and according to OECD guideline 402.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- GLP compliance:
- yes
- Test type:
- fixed dose procedure
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Wiga GmbH, Sulzfeld
- Age at study initiation: 9 weeks approximately
- Weight at study initiation: Males: 349 to 398 gms and Females: 241 to 254 gms
- Housing: Rats were individually housed in polycarbonate cages
- Diet (ad libitum): Rats were supplied by standard diet RMH-B, pellet diameter 10 mm from Hope Farms, Woerden, and The Netherlands
- Water (ad libitum): Tap water
- Acclimation period: 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19°C to 23°C
- Humidity (%): 65-95%
- Air changes (per hr):
- Photoperiod: 12hrs dark /12 hrs light
IN-LIFE DATES: From: 1987-10-02 to: 1987-10-16 - Type of coverage:
- semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: Fur from upper-dorso-lateral area of each animal was clipped to expose Approximately 10% of the total body surface area
- % coverage: Approximately 10% of the total body surface area
- Type of wrap if used: Undiluted test substance was evenly spread on surgical gauze (5×5 cm and 5×3.5 cm for males and females respectively) that was fixed to aluminum foil with a drop of Vaseline. Again with a drop of Vaseline this patch was attached to flexible bandage which was applied to clipped area of trunk of each animal and fixed with adhesive tape.
REMOVAL OF TEST SUBSTANCE
- Washing (if done): After 25 hours of exposure, the semi-occlusive bandage was removed and discarded and the remaining test substance on the treated surface was gently removed with tissues moistened with tap water.
- Time after start of exposure: 25 hours
- Duration of exposure:
- 25 hours
- Doses:
- single dose of 2000 mg/kg bw
- No. of animals per sex per dose:
- 5/sex
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: Cage-side observations were performed on the day of dosing (approximately once every 2 hours) and daily thereafter, with exception weekends and holidays a mortality check was performed at the end of the day.
- Frequency of weighing: Weekly
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight - Sex:
- male
- Dose descriptor:
- LD0
- Effect level:
- > 2 000 mg/kg bw
- Sex:
- female
- Dose descriptor:
- LD0
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- No mortalities occurred during exposure and 14 day exposure period.
- Clinical signs:
- other: No signs of systemic toxicity were observed during exposure and 14 day observation period.
- Gross pathology:
- Macroscopic examination at necropsy of all animals at the end of the study revealed no test substance related gross abnormalities.
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- Based on the results of this the dermal LD0 of TPnB in male and female rats was > 2000 mg/kg.
- Executive summary:
One group of Wistar rats comprising 5 males and 5 females was treated with a single dermal dose of TPnB (Tripropylene glycol n-butyl ether) colorless liquid at 2000 mg/kg body weight for 25 hours. Rats were received from Charles River Wiga GmbH, Sulzfeld and kept for acclimation period of 6 days. Rats were supplied by standard diet (ad libitum) RMH-B, pellet diameter 10 mm from Hope Farms, Woerden, and The Netherlands. Rats were provided (ad libitum) with tap water throughout the study period.
Undiluted test substance was evenly spread on surgical gauze (5×5 cm and 5×3.5 cm for males and females respectively) that was fixed to aluminum foil with a drop of Vaseline. Again with a drop of Vaseline this patch was attached to flexible bandage which was applied to clipped area of trunk of each animal and fixed with adhesive tape approximately 10% of the total body surface area.
Monitored for effects included clinical observations, body weights and gross pathology. The treated skin surface of the animals revealed no irritation. In addition, observations regarding changes of treated surface were performed following bandage removal and on 4, 7 and 14. No mortalities occurred during exposure and 14 day exposure period. No signs of systemic toxicity were observed during exposure and 14 day observation period. Weekly group mean body weight gain was normal.
All surviving animals were sacrificed by Co2 asphyxiation and subjected to necropsy. Macroscopic examination at necropsy of all animals at the end of the study revealed no test substance related gross abnormalities.
Based on the results of this the dermal LD0 of TPnB in male and female rats was > 2000 mg/kg.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- Good (Klimisch 1)
Additional information
Acute toxicity studies are available for the oral and dermal route and all studies are of acceptable quality (Klimisch 1 or 2).
Oral: The identified key study is the Dow/Notox-1988 study in Wistar rats administered tripropylene glycol n-butyl ether at doses of 2400, 3200 and 4200 mg/kg body weight and the LD50 (females) was 2600 mg/kg body weight, for males 3100 mg/kg body weight and the LD50 (combined) was ca. 2800 mg/kg body weight. The lowest value of 2600 mg/kg body weight will be considered for risk assessment. In the supporting studies, the LD50 was > 2000 mg/kg body weight.
Inhalation - Due to the low vapor pressure of this substance, no acute inhalation studies have been conducted (refer to study waiver).
Dermal - The identified key study is the Dow-1988 study in Wistar rats dermally exposed to a single dose of 2000 mg/kg body weight and the LD0 for both the sexes was > 2000 mg/kg body weight. In the supporting Dow-1988 study in rabbits, the dermal LD0 was > 2000 mg/kg body weight.
Justification for selection of acute toxicity – oral endpoint
GLP study in accordance with OECD TG 401
Justification for selection of acute toxicity – inhalation endpoint
Refer to study waiver
Justification for selection of acute toxicity – dermal endpoint
GLP study conducted according to OECD TG 402
Justification for classification or non-classification
The oral LD50 value for oral route is > 2000 mg/kg body weight and the dermal LD0 is > 2000 mg/kg body weight. According to the EU criteria for Classification, Labeling and Packaging (CLP) and Annex VI of the Council Directive 67/548 EEC (amended by Directive 83/467 EEC), TPnB will not be classified for acute toxicity for any route of exposure.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.